Olfr462, a pivotal member of the olfactory receptor family, orchestrates the intricate process of odorant signal transduction, culminating in the perception of smell. As a G-protein-coupled receptor (GPCR) arising from a single coding-exon gene, Olfr462 shares structural homology with neurotransmitter and hormone receptors, featuring a 7-transmembrane domain architecture. Situated in the nose, Olfr462 interacts with odorant molecules, initiating a neuronal response that leads to the perception of distinct smells. This receptor's involvement in GPCR-mediated transduction of odorant signals highlights its crucial role in deciphering the olfactory code, contributing to the rich tapestry of sensory experiences. The olfactory receptor gene family, of which Olfr462 is a prominent member, stands as the largest in the genome, underscoring the complexity and diversity inherent in the olfactory system. The nomenclature assigned to olfactory receptor genes and proteins for this organism remains independent of other organisms, emphasizing the unique characteristics of this receptor family. Olfr462's function extends beyond mere molecular recognition, as it actively participates in signaling cascades that modulate neuronal responses to diverse odorants. Its significance lies not only in initiating these responses but also in its role within broader cellular processes associated with GPCR-mediated transduction.
The inhibition of Olfr462 involves a nuanced interplay of diverse mechanisms that target key components of the olfactory signal transduction pathway. Chemical inhibitors impact various intracellular processes, such as calcineurin, TGF-β receptors, calcium channels, JNK, NF-κB, and more, influencing Olfr462 function through intricate modulation of downstream cascades. These inhibitors act as finely tuned regulators, disrupting specific pathways associated with GPCR-mediated signal transduction. The multilayered nature of inhibition underscores the intricate web of molecular events that Olfr462 orchestrates, providing researchers with a rich landscape for exploration. This comprehensive understanding of Olfr462 and its inhibition contributes valuable insights to the field of olfactory receptor research, unraveling the complexities of sensory perception at the molecular level.
SEE ALSO...
Items 1 to 10 of 11 total
Display:
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
Cyclosporin A | 59865-13-3 | sc-3503 sc-3503-CW sc-3503A sc-3503B sc-3503C sc-3503D | 100 mg 100 mg 500 mg 10 g 25 g 100 g | $63.00 $92.00 $250.00 $485.00 $1035.00 $2141.00 | 69 | |
Calcineurin inhibitor disrupting GPCR signaling. Alters intracellular processes involved in olfactory signal transduction, potentially inhibiting Olfr462 function through the modulation of calcium-dependent cascades. | ||||||
SB 431542 | 301836-41-9 | sc-204265 sc-204265A sc-204265B | 1 mg 10 mg 25 mg | $82.00 $216.00 $416.00 | 48 | |
TGF-β receptor inhibitor influencing downstream signaling pathways. Indirectly impacts Olfr462 function by disrupting TGF-β-related processes involved in GPCR-mediated signal transduction. | ||||||
Nifedipine | 21829-25-4 | sc-3589 sc-3589A | 1 g 5 g | $59.00 $173.00 | 15 | |
Calcium channel blocker affecting intracellular calcium levels. Modulates GPCR-related signaling pathways, potentially inhibiting Olfr462 function through the alteration of calcium-dependent processes in olfactory signal transduction. | ||||||
SP600125 | 129-56-6 | sc-200635 sc-200635A | 10 mg 50 mg | $40.00 $150.00 | 257 | |
c-Jun N-terminal kinase (JNK) inhibitor impacting MAPK signaling. Modifies cellular responses downstream of GPCR activation, potentially inhibiting Olfr462 function through the JNK-mediated modulation of MAPK cascades. | ||||||
Parthenolide | 20554-84-1 | sc-3523 sc-3523A | 50 mg 250 mg | $81.00 $306.00 | 32 | |
NF-κB inhibitor influencing GPCR-related pathways. Modifies intracellular processes, potentially inhibiting Olfr462 function through the disruption of NF-κB-mediated cascades involved in olfactory signal transduction. | ||||||
EGTA | 67-42-5 | sc-3593 sc-3593A sc-3593B sc-3593C sc-3593D | 1 g 10 g 100 g 250 g 1 kg | $21.00 $65.00 $120.00 $251.00 $815.00 | 23 | |
Calcium chelator affecting GPCR-mediated signal transduction. Alters calcium-dependent processes, indirectly influencing Olfr462 function by modulating downstream signaling cascades. | ||||||
VX 745 | 209410-46-8 | sc-361401 sc-361401A | 10 mg 50 mg | $183.00 $842.00 | 4 | |
p38 MAP kinase inhibitor impacting MAPK signaling pathways. Modulates cellular responses downstream of GPCR activation, potentially inhibiting Olfr462 function through the p38-mediated modulation of MAPK cascades. | ||||||
YM 90709 | 163769-88-8 | sc-361414 | 10 mg | $189.00 | ||
mTOR inhibitor affecting cellular processes associated with olfactory signal transduction. Indirectly inhibits Olfr462 by suppressing mTOR-dependent events, impacting downstream GPCR signaling pathways. | ||||||
Gö 6976 | 136194-77-9 | sc-221684 | 500 µg | $227.00 | 8 | |
PKC inhibitor targeting downstream GPCR signaling. Modifies intracellular pathways involved in olfactory signal transduction, potentially inhibiting Olfr462 function through PKC-mediated processes. | ||||||
LY 303511 | 154447-38-8 | sc-202215 sc-202215A | 1 mg 5 mg | $67.00 $278.00 | 3 | |
PI3-kinase inhibitor impacting GPCR-related signaling pathways. Modulates intracellular processes, indirectly influencing Olfr462 function through the disruption of PI3-kinase-dependent cascades. | ||||||